Medtronic plc
Every calculator, already run for MDT
Open the full toolkit →You have the numbers on MDT. Get the argument.
A written report on which of these readings actually decide the outcome for Medtronic plc, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
28 analysts covering MDTAnalyst Price Target Disagreement for Medtronic plc
Wall Street's bull case implies +31% from the current price; the bear case implies -8%. A 39% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for MDT
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent graft…
MDT — frequently asked
Is MDT a buy right now?
Wall Street's consensus rating on Medtronic plc is Buy across 28 analysts, with a mean price target of $104.83 (+14% vs. the current $92.13). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is MDT overvalued?
MDT trades at 22.7x trailing earnings, against a DCF fair value of $141 per share. The current price implies 1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is MDT's next earnings date?
Medtronic plc is next scheduled to report earnings around Nov 17, 2026. A full MDT research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Medtronic plc?
Analysts covering Medtronic plc (MDT) range from a bear-case target of $85.00 to a bull-case high of $121.00, with a mean consensus target of $104.83 across 24 analysts. The spread of $36.00 (39% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Medtronic plc against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Medtronic plc
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full MDT research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Medtronic plc, in minutes. 3 free reports included with every account — no credit card required.